Genotype 3: Treat now or wait for something better?
- PMID: 31041008
- PMCID: PMC6490668
- DOI: 10.1002/cld.510
Genotype 3: Treat now or wait for something better?
Similar articles
-
Preparing the patient for success: treat or wait?Dig Liver Dis. 2013 Sep 30;45 Suppl 5:S332-6. doi: 10.1016/j.dld.2013.07.013. Dig Liver Dis. 2013. PMID: 24091112 Review.
-
Definitive locoregional therapy (LRT) versus bridging LRT and liver transplantation with wait-and-not-treat approach for very early stage hepatocellular carcinoma.Diagn Interv Radiol. 2018 Jul;24(4):213-218. doi: 10.5152/dir.2018.17418. Diagn Interv Radiol. 2018. PMID: 30091712 Free PMC article.
-
Metabolomic analysis of Gyejibongnyeong-Hwan for shoulder pain: A randomized, wait-list controlled pilot trial.Phytomedicine. 2022 Sep;104:154248. doi: 10.1016/j.phymed.2022.154248. Epub 2022 Jun 9. Phytomedicine. 2022. PMID: 35716471 Clinical Trial.
-
HCV F1/F2 patients: treat now or continue to wait.Liver Int. 2014 Feb;34 Suppl 1:79-84. doi: 10.1111/liv.12408. Liver Int. 2014. PMID: 24373082 Review.
-
Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?Liver Int. 2013 Feb;33 Suppl 1:105-10. doi: 10.1111/liv.12066. Liver Int. 2013. PMID: 23286853 Review.
References
-
- World Health Organization . Hepatitis C. http://www.who.int/mediacentre/factsheets/fs164/en/. Updated July 2015. Accessed July 29, 2015.
-
- Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, Müllhaupt B, et al.; Swiss Hepatitis C Cohort Study Group . Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol 2009;51:655‐666. - PubMed
-
- Lawitz E, Mangia A, Wyles D, Rodriguez‐Torres M, Hassanein T, Gordon SC, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013;368:1878‐1887. - PubMed
-
- Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez‐Torres M, Sulkowski MS, et al.; POSITRON Study ; FUSION Study . Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med 2013;368:1867‐1877. - PubMed
-
- Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, et al.; VALENCE Investigators . Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med 2014;370:1993‐2001. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources